The abstract is read at the publisher; the summary is JClub's.
A dual-dimensional model combining a 17-gene TLS functional signature with a four-gene basal-squamous signature stratifies survival and immunotherapy response in UTUC, including TLS-positive/basal-high (Q3) patients with poor outcomes.
- Why it matters: UTUC has poor prognosis and modest immunotherapy response, but how TLS functional heterogeneity and its spatial interaction with tumor epithelium shape outcomes is unclear.
- What they did: Single-cell RNA-seq (n=4) and Xenium spatial transcriptomics (n=20) mapped TLS zones and trained a 17-gene, four-module TLS signature plus a four-gene basal-squamous signature, then validated across TCGA-BLCA, IMvigor210 (n=348), and GSE32894 (n=224).
- The result: TLS-positive microenvironments show enhanced antigen presentation and cytotoxic activity, while basal-squamous cells co-localize with TLS and form immunosuppressive niches linked to SPP1/FN1-mediated fibrosis and checkpoint upregulation; the model stratified survival (log-rank p<0.05) and associated with immunotherapy response in IMvigor210.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.